Tag: Cancer: Brain
Novel Immunotherapy May Up Survival in Melanoma Brain Mets
Findings in patients receiving checkpoint blockade immunotherapy for melanoma brain metastases
Nivolumab + Ipilimumab Shows Efficacy for Untreated Brain Mets
Findings from open-label, phase 2 study in patients with melanoma and untreated brain metastases
Polio-Rhinovirus Promising for Malignant Glioma Patients
Intratumoral infusion appears to be safe, improve survival in those with grade IV malignant glioma
TTFields Tied to Improved Survival in Glioblastoma Patients
No negative influence on health-related quality of life apart from more itchy skin, which was expected
Variation Seen in Hospice Use for Malignant Glioma
Differences by race, sex, age, level of education, urban versus rural residence identified
Drug Combo Doesn’t Lengthen Glioblastoma Survival
Lomustine+bevacizumab may increase progression-free, but not overall, survival versus lomustine alone
Overall Survival Up for Melanoma Brain Metastases
Median overall survival from time of diagnosis has increased from 7.5 to 22.7 months
Vaccine-Chemotherapy Combo Promising in Glioblastoma
Four of the 11 patients in study survived for more than five years after vaccine/chemo treatment
AACR: TTFields + Temozolomide Ups Survival in Glioblastoma
Compliance with TTFields treatment predicts outcome, with better outcome for >18 hour/day
Study Finds No Link Between Cytomegalovirus, Glioblastoma
Researchers find no evidence of cytomegalovirus in tumor tissue
